MGO One Seven’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
– Sell
-1,544
Closed -$239K – 473
2020
Q1
$239K Sell
1,544
-3,073
-67% -$358K 0.08% 325
2019
Q4
$386K Sell
4,617
-1,569
-25% -$119K 0.1% 277
2019
Q3
$419K Buy
6,186
+8
+0.1% +$527 0.12% 231
2019
Q2
$410K Buy
6,178
+990
+19% +$57.7K 0.13% 217
2019
Q1
$288K Buy
5,188
+2,559
+97% +$156K 0.09% 288
2018
Q4
$130K Buy
2,629
+16
+0.6% +$979 0.06% 386
2018
Q3
$225K Buy
+2,613
New +$186K 0.11% 279
2018
Q1
$115K Buy
2,845
+2,011
+241% +$75.9K 0.05% 400
2017
Q4
$29K Buy
+834
New +$27.7K 0.01% 764

Other funds holding TDOC

MGO One Seven's TDOC Position: Q2 2020 in Review

MGO One Seven sold out of Teladoc Health (TDOC) in Q2 2020, closing a stake of 1,544 shares — an estimated $239K sold.

MGO One Seven first reported a position in TDOC in Q4 2017 and held it in 9 quarters. The position peaked at $419K in Q3 2019. 670 funds tracked by Wall St. Rank hold TDOC as of Q2 2020.

  • MGO One Seven reported no remaining Teladoc Health position as of Q2 2020 after selling out during the quarter.
  • MGO One Seven sold 1,544 Teladoc Health shares in Q2 2020, an estimated $239K.
  • MGO One Seven first reported a position in Teladoc Health in Q4 2017 and held it in 9 quarters.
  • MGO One Seven's Teladoc Health position peaked at $419K in Q3 2019.
  • 670 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2020.

Based on MGO One Seven's 13F filing for Q2 2020, filed 12 Aug 2020.